Top Markets
Coin of the day
GH Research PLC GH Research PLC

GH Research PLC

GHRS
Ранг среди акций #6594
GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to... GH Research PLC is a clinical-stage biopharmaceutical firm dedicated to creating novel therapies for psychiatric and neurological conditions. The company primarily concentrates on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) treatments, specifically targeting patients with treatment-resistant depression (TRD). Its most advanced program is GH001, an inhalable 5-MeO-DMT product candidate that has successfully completed two Phase 1 clinical trials and a subsequent Phase 1/2 clinical trial in TRD patients. Additionally, GH Research is developing GH002, an injectable 5-MeO-DMT candidate, and GH003, an intranasal 5-MeO-DMT candidate. Both GH002 and GH003 are currently in preclinical development, with a focus on their potential applications in various psychiatric and neurological disorders. Founded in 2018, GH Research PLC is headquartered in Dublin, Ireland.
Цена акции
$28.53
Последняя синхронизация: 2026-08-27
Рыночная капитализация
$1.96B
Изменение (1 день)
-1.65%
Изменение (1 год)
106.14%
Страна
IE
Торговля GH Research PLC (GHRS)

Категория

История дроблений акций GH Research PLC (GHRS)
Акции GH Research PLC (символ: GHRS) прошли через 0 дроблений.
Последнее дробление произошло Aug 28, 2026.
Одна акция GHRS, купленная до Aug 28, 2026, сейчас соответствует 0 акциям GHRS.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
Недостаточно данных для указанных дат.
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH